07/01
Headlines

Mark DeFrance

Mark DeFrance is a senior research analyst at Tech Insider, focusing on the enterprise software sector. Prior to joining TI, Mark covered enterprise software for First Albany, and prior to that he worked in equity research at B.T. Alex Brown and Bankers Trust. Mark has written software applications in various programming languages including BASIC, Pascal, and COBOL. He has also been recognized in The Wall Street Journal's "Best on the Street" survey and was recognized by Forbes Magazine as the No. 1 sell-side stock picker in the software industry for a five-year period, with returns of 115% versus 26% for the software industry.

Active Movers: Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Groupon Inc (NASDAQ:GRPN), Twenty-First Century Fox Inc (NASDAQ:FOXA), Sirius XM Holdings Inc. (NASDAQ:SIRI), DryShips Inc. (NASDAQ:DRYS)

Mark DeFrance03 mins

The U.S. drug maker offered Idenix Pharmaceuticals Inc. (NASDAQ:IDIX) shareholders $24.50 a share, or $3.85 billion, for the developer of hepatitis C drugs. That’s almost quadruple the stock’s average unaffected price over the previous 20 days, the highest premium on record for any health care deal of at least $100 million, according to data compiled…

Read More

Consumer Goods Active Stocks: Apple Inc. (NASDAQ:AAPL), Hillshire Brands (NYSE:HSH), General Motors Company (NYSE:GM), Procter & Gamble (NYSE:PG), Coca-Cola (NYSE:KO)

Mark DeFrance03 mins

Apple Inc. (NASDAQ:AAPL) shares swung higher on Monday as investors remained upbeat on the US tech giant in the first day of trading after a 7-for-1 stock split. Apple gained 1.5 percent to close at $93.70, still below the all-time high in September 2012 of just over $100, on a basis adjusted for Monday’s split….

Read More

Tech New Highs: Intel Corporation (NASDAQ:INTC), Skyworks Solutions Inc (NASDAQ:SWKS), Wave Systems Corp. (NASDAQ:WAVX), TriQuint Semiconductor (NASDAQ:TQNT), Intersil Corp (NASDAQ:ISIL)

Mark DeFrance03 mins

Intel Corporation (NASDAQ:INTC)-GE Care Innovations™ today announced a partnership with Predilytics, a health care information technology company, that will advance Care Innovations’ ability to harness behavior and vital sign data, collected from the home and during the course of daily life, to improve care delivery and population engagement. Intel Corporation (NASDAQ:INTC) stock performance was -0.22%…

Read More
FB Nasdaq FB Facebook

Healthcare Active Stocks: AstraZeneca plc (ADR) (NYSE:AZN), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Gilead Sciences, Inc. (NASDAQ:GILD)

Mark DeFrance03 mins

AstraZeneca Plc (ADR) (NYSE:AZN), in the headlines for spurning buyout offers from Pfizer Inc, aims to regain prominence in oncology with compelling trial results and a splashy exhibit booth at the world’s largest meeting of cancer doctors. AstraZeneca plc (ADR) (NYSE:AZN) stock performance was -0.83% in last session and finished the day at $72.76. Traded…

Read More

Airline Stocks: Textron Inc. (NYSE:TXT), Northrop Grumman Corporation (NYSE:NOC), The Boeing Company (NYSE:BA), Micronet Enertec Technologies Inc (NASDAQ:MICT)

Mark DeFrance02 mins

Textron Inc. (NYSE:TXT)’s defense systems subsidiary has secured a $190 million contract from the U.S. Air Force to provide 361 sensor fuzed weapons, seven trainers and 18 wind corrected munitions dispenser tail kits, some of which will be supplied to South Korea’s military, the U.S. Department of Defense said Thursday. Textron Inc. (NYSE:TXT) stock performance…

Read More
FB Nasdaq FB Facebook

Biotech Bullish Stocks: TrovaGene Inc (NASDAQ:TROV), Vital Therapies (NASDAQ:VTL), RXi Pharmaceuticals (NASDAQ:RXII), Applied Genetic Technologies Corp (NASDAQ:AGTC), IGI Laboratories (NYSEMKT:IG)

Mark DeFrance03 mins

TrovaGene Inc (NASDAQ:TROV) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at TROV given that, according to its RSI reading of 24.68, it is now in oversold territory….

Read More